======= ANKRD2 =======
== Gene Information ==
* **Official Symbol**: ANKRD2
* **Official Name**: ankyrin repeat domain 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26287|26287]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9GZV1|Q9GZV1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ANKRD2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANKRD2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610734|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a protein that belongs to the muscle ankyrin repeat protein (MARP) family. A similar gene in rodents is a component of a muscle stress response pathway and plays a role in the stretch-response associated with slow muscle function. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014].
* **UniProt Summary**: Functions as a negative regulator of myocyte differentiation. May interact with both sarcoplasmic structural proteins and nuclear proteins to regulate gene expression during muscle development and in response to muscle stress. {ECO:0000269|PubMed:21737686, ECO:0000269|PubMed:22016770}.
|Ank|
|Ank 2|
|RNA polymerase II-specific DNA-binding transcription factor binding|
|euchromatin|
|protein kinase B binding|
|regulation of transcription from RNA polymerase II promoter in response to oxidative stress|
|regulation of myoblast proliferation|
|titin binding|
|negative regulation of myotube differentiation|
|I band|
|negative regulation of myoblast differentiation|
|regulation of intrinsic apoptotic signaling pathway by p53 class mediator|
|negative regulation of striated muscle cell differentiation|
|structural constituent of muscle|
|skeletal muscle cell differentiation|
|regulation of myoblast differentiation|
|negative regulation of muscle cell differentiation|
|regulation of myotube differentiation|
|PML body|
|regulation of striated muscle cell differentiation|
|regulation of transcription from RNA polymerase II promoter in response to stress|
|skeletal muscle tissue development|
|regulation of DNA-templated transcription in response to stress|
|skeletal muscle organ development|
|regulation of muscle cell differentiation|
|regulation of intrinsic apoptotic signaling pathway|
|regulation of signal transduction by p53 class mediator|
|cellular response to oxidative stress|
|muscle contraction|
|striated muscle tissue development|
|muscle organ development|
|muscle tissue development|
|muscle system process|
|response to oxidative stress|
|chromatin binding|
|regulation of apoptotic signaling pathway|
|muscle structure development|
|intracellular membrane-bounded organelle|
|regulation of cytokine production|
|negative regulation of cell differentiation|
|negative regulation of transcription by RNA polymerase II|
|negative regulation of developmental process|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|regulation of apoptotic process|
|negative regulation of biosynthetic process|
|regulation of programmed cell death|
|regulation of cell population proliferation|
|regulation of cell death|
|cellular response to stress|
|negative regulation of gene expression|
|tissue development|
|regulation of cell differentiation|
|regulation of intracellular signal transduction|
|system process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp432|YM155 0.001μM R08 exp432]]|-1.94|
|[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|-1.7|
|[[:results:exp218|A-395 10μM R05 exp218]]|1.8|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.402|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13703
* **Expression level (log2 read counts)**: -6.6
{{:chemogenomics:nalm6 dist.png?nolink |}}